EUVIMEDEUVIMED entdecken
Open Access

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Lihong Wang-Bishop, Blaise R Kimmel iD, Verra M Ngwa iD, Matthew Z Madden iD, Jessalyn J Baljon iD, David C Florian iD, Ann Hanna, Lucinda E Pastora, Taylor L Sheehy iD, Alexander J Kwiatkowski iD, Mohamed Wehbe, Xiaona Wen iD und 14 weitere

Science Immunology · 26.05.2023 · 8 (83)

DOI: 10.1126/sciimmunol.add1153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 26.05.2023. Verfasst von Lihong Wang-Bishop und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor-associated vasculature imposes major structural and biochemical barriers to the infiltration of effector T cells and effective tumor control. Correlations between stimulator of interferon genes (STING) pathway activation and spontaneous T cell infiltration in human cancers led us to evaluate the effect of STING-activating nanoparticles (STANs), which are a polymersome-based platform for the delivery of a cyclic dinucleotide STING agonist, on the tumor vasculature and attendant effects on T cell infiltration and antitumor function. In multiple mouse tumor models, intravenous administration of STANs promoted vascular normalization, evidenced by improved vascular integrity, reduced tumor hypoxia, and increased endothelial cell expression of T cell adhesion molecules. STAN-mediated vascular reprogramming enhanced the infiltration, proliferation, and function of antitumor T cells and potentiated the response to immune checkpoint inhibitors and adoptive T cell therapy. We present STANs as a multimodal platform that activates and normalizes the tumor microenvironment to enhance T cell infiltration and function and augments responses to immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesMiceAnimalsHumansImmunotherapyT-LymphocytesDisease Models, AnimalTumor Microenvironment

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Civil and Environmental Engineering, Vanderbilt University, Nashville, TN 37232, USA.

ORCID-Profile: Blaise R Kimmel, Verra M Ngwa, Matthew Z Madden, Jessalyn J Baljon, David C Florian, Taylor L Sheehy, Alexander J Kwiatkowski, Xiaona Wen, Kyle W Becker, Kyle M Garland, Deanna Edwards, Melissa M Wolf, Rossane Delapp, Plamen P Christov, Kathryn E Beckermann, Justin M Balko, W Kimryn Rathmell, Jeffrey C Rathmell, Jin Chen, John T Wilson

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Wang-Bishop, L., Kimmel, B. R., Ngwa, V. M., Madden, M. Z., Baljon, J. J., Florian, D. C., Hanna, A., Pastora, L. E., Sheehy, T. L., Kwiatkowski, A. J., Wehbe, M., Wen, X., Becker, K. W., Garland, K. M., Schulman, J. A., Shae, D., Edwards, D., Wolf, M. M., Delapp, R., …, & Wilson, J. T. (2023). STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Science Immunology, 8(83). https://doi.org/10.1126/sciimmunol.add1153

Vancouver

Wang-Bishop L, Kimmel BR, Ngwa VM, Madden MZ, Baljon JJ, Florian DC, et al. STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Science Immunology. 2023;8(83). doi:10.1126/sciimmunol.add1153

BibTeX
@article{WangBishop2023,
  author = {Wang-Bishop, Lihong and Kimmel, Blaise R and Ngwa, Verra M and Madden, Matthew Z and Baljon, Jessalyn J and Florian, David C and Hanna, Ann and Pastora, Lucinda E and Sheehy, Taylor L and Kwiatkowski, Alexander J and Wehbe, Mohamed and Wen, Xiaona and Becker, Kyle W and Garland, Kyle M and Schulman, Jacob A and Shae, Daniel and Edwards, Deanna and Wolf, Melissa M and Delapp, Rossane and Christov, Plamen P and Beckermann, Kathryn E and Balko, Justin M and Rathmell, W Kimryn and Rathmell, Jeffrey C and Chen, Jin and Wilson, John T},
  title = {STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy},
  journal = {Science Immunology},
  year = {2023},
  volume = {8},
  number = {83},
  doi = {10.1126/sciimmunol.add1153}
}
Kostenlos starten →